ArticleScientific reports2025
MS-EmoBoost: a novel strategy for enhancing self-supervised speech emotion representations.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Extracting richer emotional representations from raw speech is one of the key approaches to improving the accuracy of Speech Emotion Recognition (SER). In recent years, there has been a trend in utilizing self-supervised learning (SSL) for extracting SER features, due to the exceptional performance of SSL in Automatic Speech Recognition (ASR). However, existing SSL methods are not sufficiently sensitive in capturing emotional information, making them less effective for SER tasks. To overcome this issue, this study proposes MS-EmoBoost, a novel strategy for enhancing self-supervised speech emotion representations. Specifically, MS-EmoBoost uses the deep emotional information from Melfrequency cepstral coefficient (MFCC) and spectrogram as guidance to enhance the emotional representation capabilities of self-supervised features. To determine the effectiveness of our proposed approach, we conduct a comprehensive experiment on three benchmark speech emotion datasets: IEMOCAP, EMODB, and EMOVO. The SER performance is measured by weighted accuracy (WA) and unweighted accuracy (UA). The experimental results show that our method successfully enhances the emotional representation capability of wav2vec 2.0 Base features, achieving competitive performance in SER tasks (IEMOCAP:WA,72.10%; UA,72.91%; EMODB:WA,92.45%; UA,92.62%; EMOVO:WA,86.88%; UA,87.51%), and proves effective for other self-supervised features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.